VANCOUVER, July 24, 2018 /CNW/ - A new organization has been established to help in the fight to curb the opioid overdosecrisis. The Addiction Care Clinics of BC will represent the dozens of non-government clinics that currently provide addiction treatment in over 30 communities throughout the province, with a strong focus on recovery. The newly formed ACCBC has arisen
"It is time for the many addiction care clinics in the province to offer their expertise to the discussions on how to maximize recovery and further reverse the current opioid overdose crisis," says Dr. Alan Brookstone, addiction doctor and spokesperson for the group. "We feel our constructive ideas can add value to current efforts."
At a time when the numbers of overdose deaths remain at record highs and while many innovative interventions are being tried, the ongoing life-saving work in these non-government clinics seems to be overlooked. The members of ACCBC feel that more needs to be done to study the success of these clinics, to analyze their cost effectiveness and to remove barriers to access.
"Ours is a life-saving intervention that should be made more available during this crisis of overdose deaths," says Dr. Alan Brookstone. "We invite research into our model which we believe has good outcomes and is very cost-effective. Governments should be looking to remove financial and other barriers. We will approach the BC Centre on Substance Use and the Ministry of Mental Health and Addictions with ideas on how to maximize our contribution to dealing with the overdose crisis."
The current attempts to curb the overdose crisis focuses on everything except the one program that is already in place that is saving lives on a daily basis. There is no need to reinvent the wheel. We need to maximize access and remove barriers to the a critical program that is working now.
SOURCE Addiction Care Clinics of British Columbia
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All